You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
四环医药(00460.HK)反覆回升逾9% 旗下药品通过一致性评价
阿思达克 02-09 15:03
四环医药(00460.HK)旗下醋酸奥曲(月太)注射液通过一致性评价,该股扭转由近三年高位连吐两天势,今天跑赢同业,股价反覆重越10天线(2.09元),高低见2.35元/2.01元,现造2.26元,反覆回升9.2%,但成交未能配合仅1.19亿股,涉资2.67亿元。

四环医药表示,旗下醋酸奥曲(月太)注射液已获得国家药品监督管理局颁发药品补充申请批准通知书,该药品通过质量和疗效一致性评价,为该品种首家通过一致性评价。该药是国家医保乙类药品,是人工合成天然生长抑素的八(月太)衍生物,较天然生长抑素半衰期明显延长且有相同药理作用,包括抑制生长激素功能,抑制胃酸、胰(酉每)、胰高血糖素和胰岛素的分泌,减少内脏血流量,降低胃肠道运动等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account